Edition:
United States

ACADIA Pharmaceuticals Inc (ACAD.OQ)

ACAD.OQ on NASDAQ Stock Exchange Global Select Market

19.85USD
24 Sep 2018
Change (% chg)

$-0.32 (-1.59%)
Prev Close
$20.17
Open
$20.22
Day's High
$20.60
Day's Low
$19.72
Volume
850,625
Avg. Vol
872,136
52-wk High
$41.20
52-wk Low
$12.80

Chart for

About

ACADIA Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines for central nervous system (CNS) disorders. Its lead drug candidate, NUPLAZID (pimavanserin), is used for the treatment of hallucinations and delusions associated with Parkinson's disease... (more)

Overall

Beta: 3.51
Market Cap(Mil.): $2,521.39
Shares Outstanding(Mil.): 125.01
Dividend: --
Yield (%): --

Financials

  ACAD.OQ Industry Sector
P/E (TTM): -- 108.33 32.69
EPS (TTM): -1.47 -- --
ROI: -53.67 1.50 12.72
ROE: -53.77 0.19 14.85

BRIEF-Acadia Pharmaceuticals Q1 Loss Per Share $0.44

* ACADIA PHARMACEUTICALS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS

May 04 2018

BRIEF-Acadia Pharmaceuticals Says CEO Stephen Davis's FY 2017 Total Compensation Was $15.2 Mln

* ACADIA PHARMACEUTICALS SAYS CEO STEPHEN DAVIS'S FY 2017 TOTAL COMPENSATION WAS $15.2 MILLION, INCLUDING $13.9 MILLION IN OPTION AWARDS - SEC FILING Source : https://bit.ly/2ra1j3J Further company coverage: (Reuters.Briefs@thomsonreuters.com)

Apr 30 2018

FDA says reviewing Acadia's Parkinson's medication, shares fall

WASHINGTON The U.S. Food and Drug Administration said on Wednesday it was reviewing Acadia Pharmaceuticals' Parkinson's medication, the only approved drug used to treat hallucinations and delusions associated with the disease.

Apr 25 2018

FDA says reviewing Acadia's Parkinson's medication, shares fall

WASHINGTON, April 25 The U.S. Food and Drug Administration said on Wednesday it was reviewing Acadia Pharmaceuticals' Parkinson's medication, the only approved drug used to treat hallucinations and delusions associated with the disease.

Apr 25 2018

Competitors

  Price Chg
Pfizer Inc. (PFE.N) $43.93 -0.13
Eli Lilly And Co (LLY.N) $105.59 -0.74
Eisai Co., Ltd (4523.T) ¥10,575 +305.00

Earnings vs. Estimates